approval - International Pharmaceutical Industry

Volume 15 Issue 3

Antibody Drug Conjugates and the Link to Fighting Cancer

Antibody drug conjugates (ADCs) are a big deal in oncology. And rightly so: they combine highly specific targeting with a potent cytotoxic payload to deliver tremend...

29 September 2023 Volume 15 Issue 3 ADCs | antibody

Continue Reading →

Volume 14 Issue 4

EU CTR: Final Countdown, What You Need to Know

The end of the transition period is imminent. How can clinical trial sponsors and CROs ease the transition to CTIS? Soon, the one-year transition period of the EU...

13 January 2023 Volume 14 Issue 4 application | approval

Continue Reading →

Volume 14 Issue 4

Brexit – Impact, Challenges, and Solutions for The Pharmaceutical Industry

Brexit has provided several challenges to the pharmaceutical industry that required robust actions and swift resolution in order to remain in compliance following th...

13 January 2023 Volume 14 Issue 4 approval | Brexit

Continue Reading →

News

CHMP recommends approval of Cablivi(TM) (caplacizumab)

First therapeutic to receive positive CHMP opinion for treatment of a rare blood disorder called acquired thrombotic thrombocytopenic purpura The European Me...

3 July 2018 News approval | blood

Continue Reading →

News

WuXi STA first CDMO to support the approval of an innovative drug in China through the “MAH” pilot

WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo® STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces that its...

19 June 2018 News approval | CDMO

Continue Reading →

News

GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD

First filing made for a triple therapy for chronic obstructive pulmonary disease offered in a single inhaler. Chronic obstructive pulmonary disease (COPD) affects...

5 June 2018 News Applies | approval

Continue Reading →

News

Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma

DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple mye...

8 May 2018 News announces | approval

Continue Reading →

News

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

Invivoscribe Technologies, Inc. announced today that they have submitted to Japan's Pharmaceutical and Medical Devices Agency (PMDA) and the US Food and Drug Adminis...

8 May 2018 News application | approval

Continue Reading →

News

FDA approval for Novartis' melanoma combo

The FDA has approved Novartis' Tafinlar(dabrafenib) in combination with Mekinist (trametinib) for the adjuvant treatment of BRAF V600E or V600K mutation-positiv...

1 May 2018 News approval | combo

Continue Reading →

News

Wickham Laboratories Holdings Announces Planning Application Approval

Outline planning permission application for expansion of the Hoeford Point site now approved. Wickham Laboratories Holdings, owner of Wickham Laboratories Ltd...

23 January 2018 News application | approval

Continue Reading →